Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Update on US regulatory decision for Farxiga in type-1 diabetes
-
Imfinzi granted US Orphan Drug Designation for small cell lung cancer
-
Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data
-
Fasenra receives positive EU CHMP opinion for self-administration and the new Fasenra pen, a pre-filled, single-use auto-injector
-
Imfinzi improves overall survival at interim analysis in the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
-
Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
-
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
Bevespi Aerosphere approved by the Japanese Ministry of Health, Labour and Welfare for patients with chronic obstructive pulmonary disease
-
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer
-
Calquence significantly prolonged the time patients lived without disease progression in relapsed or refractory chronic lymphocytic leukaemia
Latest articles and press releases
All of our latest press releases and articles are available to explore
